Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nasal Spray Container Determination Should Precede Clinical Testing – FDA

This article was originally published in The Tan Sheet

Executive Summary

Container closure systems for nasal spray and inhalant drugs should be tested and found appropriate for use with a particular drug compound prior to conducting clinical and stability tests, an FDA guidance states

You may also be interested in...



Metered dose inhalers

Dose-counting mechanisms for metered dose oral inhalers recommended by FDA in Dec. 11 Federal Register. Guidance, noting patients may either use products for too long or throw away inhalers that still have acceptable doses left in them, states "dose-counters should provide, either though a direct numeric count or color coding, a clear indication of when an MDI is approaching the end of its recommended number of actuations, as well as when it has reached or exceeded that number"...

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

LL016481

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel